pristanic acid has been researched along with Cerebro-Hepato-Renal Syndrome in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (90.91) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, PG; Dekker, C; Gootjes, J; Mooijer, PA; Poll-The, BT; Wanders, RJ; Waterham, HR | 1 |
| Molzer, B; Schmitt, K; Stöckler, S; Tulzer, G; Tulzer, W | 1 |
| Eyssen, HJ; Huang, S; Mannaerts, GP; Van Veldhoven, PP | 1 |
| Crane, DI; Paton, BC; Poulos, A; Sharp, PC | 1 |
| Björkhem, I; Kase, BF | 1 |
| Denis, S; van Grunsven, EG; van Roermund, CW; Wanders, RJ | 1 |
| Jakobs, C; Jansen, GA; Kok, RM; Schor, DS; ten Brink, HJ; Verhoeven, NM; Wanders, RJ | 1 |
| Christensen, E; Jakobs, C; Leth, H; Pedersen, SA; Schutgens, RB; Wanders, RJ | 1 |
| Jakobs, C; Jansen, GA; Schor, DS; Verhoeven, NM; Wanders, RJ | 1 |
| Jakobs, C; Kok, RM; Roe, CR; Roe, DS; Verhoeven, NM; Wanders, RJ | 1 |
| Johnson, D; Poulos, A; Singh, H; Usher, S | 1 |
11 other study(ies) available for pristanic acid and Cerebro-Hepato-Renal Syndrome
| Article | Year |
|---|---|
Biochemical markers predicting survival in peroxisome biogenesis disorders.
Topics: Acyltransferases; Biomarkers; Fatty Acids; Fibroblasts; Humans; Oxidation-Reduction; Peroxisomal Disorders; Peroxisomes; Phenotype; Phytanic Acid; Plasmalogens; Predictive Value of Tests; Prognosis; Retrospective Studies; Survival; Zellweger Syndrome | 2002 |
[Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
Topics: Adrenoleukodystrophy; Catalase; Fatty Acids; Humans; Infant; Male; Microbodies; Phytanic Acid; Plasmalogens; Refsum Disease; Zellweger Syndrome | 1993 |
The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Topics: Adrenoleukodystrophy; Cell Line; Fatty Acids; Fibroblasts; Humans; Kinetics; Microbodies; Oxidation-Reduction; Palmitates; Phytanic Acid; Refsum Disease; X Chromosome; Zellweger Syndrome | 1993 |
Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Australia; Bile Acids and Salts; Cells, Cultured; Enoyl-CoA Hydratase; Fatty Acids; Fibroblasts; Genetic Complementation Test; Humans; Hybrid Cells; Isomerases; Microbodies; Multienzyme Complexes; Oxidation-Reduction; Peroxisomal Bifunctional Enzyme; Peroxisomal Disorders; Phytanic Acid; Prenatal Diagnosis; Zellweger Syndrome | 1996 |
Studies on the degradation of [U-3H]-phytanic acid and [U-3H]-pristanic acid in cultured fibroblasts from children with peroxisomal disorders.
Topics: Cells, Cultured; Child; Fatty Acids; Fibroblasts; Humans; Microbodies; Phytanic Acid; Tritium; Zellweger Syndrome | 1996 |
Complementation analysis of fibroblasts from peroxisomal fatty acid oxidation deficient patients shows high frequency of bifunctional enzyme deficiency plus intragenic complementation: unequivocal evidence for differential defects in the same enzyme prote
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Cell Fusion; Cell Line; Enoyl-CoA Hydratase; Fatty Acids; Fibroblasts; Genetic Complementation Test; Humans; Isomerases; Multienzyme Complexes; Oxidation-Reduction; Peroxisomal Bifunctional Enzyme; Peroxisomal Disorders; Zellweger Syndrome | 1997 |
Formation of 2,3-pristenic acid and 3-hydroxypristanic acid from pristanic acid in human liver.
Topics: Adenosine Triphosphate; Coenzyme A; Fatty Acids; Fatty Acids, Unsaturated; Humans; In Vitro Techniques; Liver; Magnesium; Oxidation-Reduction; Zellweger Syndrome | 1997 |
A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids.
Topics: Diseases in Twins; Fatty Acids; Humans; Infant, Newborn; Male; Microbodies; Oxidation-Reduction; Phytanic Acid; Zellweger Syndrome | 1997 |
Phytanic acid alpha-oxidation: decarboxylation of 2-hydroxyphytanoyl-CoA to pristanic acid in human liver.
Topics: Biomarkers; Cell Fractionation; Coenzyme A; Decarboxylation; Fatty Acids; Humans; Liver; Microbodies; Microsomes; NAD; Phytanic Acid; Zellweger Syndrome | 1997 |
Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts.
Topics: Carnitine Acyltransferases; Carnitine O-Palmitoyltransferase; Cells, Cultured; Fatty Acids; Fibroblasts; Gas Chromatography-Mass Spectrometry; Humans; Mass Spectrometry; Microbodies; Mitochondria; Oxidation-Reduction; Phytanic Acid; Zellweger Syndrome | 1998 |
Metabolism of branched chain fatty acids in peroxisomal disorders.
Topics: Adrenoleukodystrophy; Cells, Cultured; Chondrodysplasia Punctata; Fatty Acids; Fibroblasts; Heptanoic Acids; Humans; Metabolism, Inborn Errors; Microbodies; Oxidation-Reduction; Refsum Disease; Stearic Acids; Zellweger Syndrome | 1990 |